Skip to main navigation
Skip to search
Skip to main content
Korea University Pure Home
Home
Profiles
Research units
Equipment
Research output
Press/Media
Search by expertise, name or affiliation
Acute myeloid leukemia after myelodysplastic syndrome and failure of therapy with hypomethylating agents: An emerging entity with a poor prognosis
Elias Jabbour
*
, Hady Ghanem
, Xuelin Huang
, Farhad Ravandi
, Guillermo Garcia-Manero
, Susan O'brien
, Stephan Faderl
, Sherry Pierce
,
Sangbum Choi
, Srdan Verstovsek
, Mark Brandt
, Jorge Cortes
, Hagop Kantarjian
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Comment/debate
›
peer-review
16
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Acute myeloid leukemia after myelodysplastic syndrome and failure of therapy with hypomethylating agents: An emerging entity with a poor prognosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hypomethylating Agents
100%
Poor Prognosis
100%
Acute Myeloid Leukemia
100%
Myelodysplastic Syndrome
100%
Complete Remission
80%
Overall Response Rate
40%
Platelet Recovery
40%
Hypomethylating Agent Failure
40%
Multivariate Analysis
20%
Platelet Count
20%
Median Survival
20%
Survival Rate
20%
2-year Survival
20%
1-year Survival
20%
Duration of Response
20%
Novel Therapies
20%
Low Albumin
20%
Salvage Regimen
20%
Adverse Factors
20%
Leukemia Diagnosis
20%
High-dose Cytarabine
20%
First Relapse
20%
Investigational Agents
20%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Myelodysplastic Syndrome
100%
Hypomethylating Agent
100%
Platelet
60%
Multivariate Analysis
20%
Survival Rate
20%
Drug Megadose
20%
Cytarabine
20%